LLX-424

· Lilac Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LLX-424, covering 2025-10-29 to 2025-10-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones [Phase 2]